Exchange: NASDAQ·Updated 07:24 PM EST

ONCT Oncternal Therapeutics Inc

$0.5266
$0.1673
(24.11%)
Today
Closed $0.5266
$0.0834
(15.84%)
After Hours
Reported EarningsAug 8
Mkt Cap$1.56M
Vol702,150.00

About ONCT

Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534. The company was founded by David F. Hale and James B. Breitmeyer in September 1997 and is headquartered in San Diego, CA.
54

Neutral Sentiment

How do you feel about ONCT?

Advertisement|Remove ads.